FERNANDA TERESA DE LIMA
Médica, especialista em Genética Clínica, mestrado e doutorado pela Universidade Federal de São Paulo-Escola Paulista de Medicina, responsável pelo Setor de Oncogenética do Departamento de Ginecologia da UNIFESP-EPM, responsável pelo Ambulatório de Oncogenética do Instituto de Oncologia Pediátrica-Grupo de Apoio ao Adolescente e à Criança com Câncer-UNIFESP-EPM, responsável pelo Setor de Genética e Oncogenética do Hospital Israelita Albert Einstein e médica pesquisadora do Instituto Israelita de Ensino e Pesquisa Albert Einstein.
Confira a agenda de atividades
23 DE MARÇO | SÁBADO
Room 3
13:30-15:30
SESSION 4: PRESENT - FUTURE
Is proton beam therapy a real deal in pediatric neurooncology?
Pre-clinical studies in medulloblastoma: what is new?
Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
The Medulloblastoma initiative-
Liquid biopsy for pediatric neurooncology tumors. Is it possible?
Study Protocol and Perspectives: Embryonal Tumors in infants
Discussion
Moderator: Gabriela Bellas (RJ)
Moderator: Maria Luisa Sucharski Figueiredo (Brasil)
Is proton beam therapy a real deal in pediatric neurooncology?
Speaker: Michael Jenwei Chen (SP)
Pre-clinical studies in medulloblastoma: what is new?
Speaker: Carolina Nör (Estados Unidos)
Genetic Predisposition Syndromes: How new molecular technologies can help us in the diagnosis and treatment
Speaker: Fernanda Teresa de Lima (SP)
When does Precision Medicine make a difference in the treatment of our pediatric patients with brain tumors?
Speaker: Elvis Terci Valera (SP)
The Medulloblastoma initiative-
Speaker: Fernando Goldsztein (RS)
Liquid biopsy for pediatric neurooncology tumors. Is it possible?
Speaker: Liana Figueiredo Nobre (Canadá)
Study Protocol and Perspectives: Embryonal Tumors in infants
Speaker: Natália Dassi (SP)
Discussion